Download a printable agenda

13:00 – 13:20 Registration

13:20 – 13:30Welcome
Miranda Weston-Smith, Founder, BioBeat
Sally Ann Forsyth, CEO, Stevenage Bioscience Catalyst
Victoria Higgins, Senior Director, Research & Development, GSK

13:30 – 14:00Keynote
Emma Walmsley, CEO, GSK
Creating the right innovation ecosystem in the UK for cutting-edge therapies

14:00 – 15:00Panel 1: Leveraging science
This panel lives the translational journey from scientific innovation to scale up of C&GT and asks where are the biggest opportunities?
On the panel:
Aisha Hasan, Clinical Development Head, Cell and Gene Therapy Oncology, GSK
Giovanna Lombardi, Professor of Human Transplant Immunology, King’s College London
Emma Morris, Professor of Clinical Cell and Gene Therapy, UCL Institute of Immunity and Transplantation (Chair)
Sophie Papa, Clinical Reader and Honorary Consultant Medical Oncologist, Guy’s Cancer at Guy’s and St Thomas’ NHS Trust
Jane Robertson, CMO, Achilles Therapeutics

15:00 – 15:30Break

15:30 – 16:30 Panel 2: Optimising value
This panel unwraps the drivers for value in C&GT, from commercial return to impact on health.
On the panel:
Natalie Hearmon, Consultant, Health Economics and Statistics Lead, Costello Medical
Karen Hodgkin, previously COO, Cell Medica (Chair)
Angela Osborne, MD, eXmoor Pharma
Anna Outhwaite, Head of ATTC Network Coordination, Cell and Gene Therapy Catapult
Tara Raveendran, Head of Life Sciences Research, Shore Capital
Jane Whitrow, VP Business Operations, Freeline Therapeutics
16:30 – 16:35

Close and thanks
16:35 – 18:00Refreshments & Networking